Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen

Journal of Clinical Microbiology

Volumn 34, Issue 8, 1996, Pages 1880-1884

  Cormican, Martin G ^a   Marshall, Steven A ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; IMIPENEM; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; ESCHERICHIA COLI; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

BACILLI; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA;

EID: 0029953215     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.8.1880-1884.1996     Document Type: Article

References (30)

1. Arlet, G., M. Rouveau, I. Casin, P. J. M. Bouvet, P. H. Lagrange, and A. Philipon. 1994. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 β-lactamase and which were isolated in 14 French hospitals. J. Clin. Microbiol. 32:2553-2558.
2. Bradford, P. A., and C. C. Sanders. 1995. Development of test panel of β-lactamases expressed in a common Escherichia coli host background for evaluation of new β-lactam antibiotics. Antimicrob. Agents Chemother. 39: 308-313.
3. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
4. Cheng, Y., and M. Chen. 1994. Extended spectrum β-lactamases in clinical isolates of Enterobacter gergoviae and Escherichia coli in China. Antimicrob. Agents Chemother. 38:2838-2842.
5. DuBois, S. K., M. S. Marriott, and S. G. B. Amyes. 1995. TEM and SHV-derived extended spectrum β-lactamases: relationship between selection, structure, and function. J. Antimicrob. Chemother. 35:7-32.
6. Goldstein, F. W., Y. Pean, A. Rosato, J. Gertner, L. Gutmann, and the Vigil'Roc Study Group. 1993. Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicenter study in 26 French hospitals. J. Antimicrob. Chemother. 32:595-603.
7. Huovinen, S., P. Huovinen, and G. A. Jacoby. 1988. Detection of plasmid-mediated β-lactamases with DNA probes. Antimicrob. Agents Chemother. 32:175-179.
8. Jacoby, G. A., and I. Carreras. 1990. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 34:858-862.
9. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases. Antimicrob. Agent Chemother. 28:302-307.
10. Jarlier, V., M. H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
11. Jenks, P. J., Y. M. Hu, F. Danel, S. Mehtar, and D. M. Livermore. 1995. Plasmid-mediated production of class I (Amp C) β-lactamase by two Klebsiella pneumoniae isolates from the UK. J. Antimicrob. Chemother. 35:235-236.
12. Jones, R. N., E. N. Kehrberg, M. E. Erwin, S. C. Anderson, and the Fluoroquinolone Resistance Surveillance Group. 1994. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. 1. Study on the threat of emerging resistances: real or perceived? Diagn. Microbiol. Infect. Dis. 19:203-215.
13. Katsanis, G. P., J. Sporgo, M. J. Ferraro, L. Sutton, and G. A. Jacoby. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J. Clin. Microbiol. 32:691-696.
14. Kliebe, C., B. A. Nies, J. F. Meyer, R. M. Tolxdorff-Neutrzling, and B. Wiedermann. 1985. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 28:302-307.
15. Mariotte, S., P. Nordmann, and M. H. Nicolas. 1994. Extended spectrum β-lactamase in Proteus mirabilis. J. Antimicrob. Chemother. 33:925-935.
16. Meyer, K. S., C. Urban, J. A. Eagan, B. J. Berger, and J. J. Rahal. 1993. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann. Intern. Med. 119:353-358.
17. Moland, E. S., and K. S. Thompson. 1994. Extended-spectrum β-lactamases of Enterobacteriaceae. J. Antimicrob. Chemother. 33:666-668.
18. Morosini, M. I., R. Canton, J. Martinez-Beltran, M. C. Negri, J. C. Perez-Dia, F. Baquero, and J. Blazquez. 1995. New extended-spectrum TEM-type β-lactamase from Salmonella enterica subsp enterica isolated in a nosocomial outbreak. Antimicrob. Agents Chemother. 39:458-461.
19. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Neuwirth, C., E. Siebor, J. Lopez, A. Pechinot, and A. Kazmierczak. 1996. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Enterobacteriaceae. J. Clin. Microbiol. 34:76-79.
21. Payne, D. J., M. S. Marriott, and S. G. B. Amyes. 1990. Characterization of a unique ceftazidime hydrolysing β-lactamase. TEM-E2. J. Med. Microbiol. 32:131-134.
22. Philippon, A., G. Arlet, and P. H. LaGrange. 1994. Origin and impact of plasmid mediated extended-spectrum β-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. Suppl. 1:17-29.
23. Philippon, A., S. Ben-Redjeb, G. Fournier, and A. Ben-Hassen. 1989. Epidemiology of extended spectrum β-lactamases. Infection 17:347-354.
24. Pornuil, K. J., G. Rodrigo, and K. Dornbusch. 1994. Production of a plasmid mediated Amp C-like β-lactamase by a Klebsiella pneumoniae septicaemia isolate. J. Antimicrob. Chemother. 34:943-954.
25. Rice, L. B., S. H. Willey, G. A. Papanicolau, G. M. Eliopoulos, R. C. Moellering, Jr., and G. A. Jacoby. 1990. Outbreak of ceftazidime-resistance caused by extended-spectrum β-lactamase at a Massachusetts chronic care facility. Antimicrob. Agents Chemother. 34:2193-2199.
26. Roy, C., C. Sergua, M. Tirado, R. Reig, M. Hermida, D. Tervel, et al. 1986. Frequency of plasmid determined beta-lactamases in 680 consecutively isolated strains of Enterobacteriaceae. Eur. J. Clin. Microbiol. Infect. Dis. 4:146-147.
27. Sader, H. S., M. A. Pfaller, and R. N. Jones. 1994. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and inter-laboratory dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 21:203-215.
28. Sanders, C. C., J. A. Washington, A. L. Barry, and C. Shubert. 1994. Assessment of the Vitek ESBL test, abstr. D44, p. 123. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
29. Thomson, C. J., and S. G. B. Amyes. 1993. Molecular epidemiology of the plasmid-encoded TEM-1 β-lactamase in Scotland. Epidemiol. Infect. 110: 117-125.
30. Thomson, K. S., and C. C. Sanders. 1992. Detection of extended spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob. Agents Chemother. 36:1877-1882.